The systemic inflammatory condition observed in high-disease-activity RA patients and the high IL-6 levels increases the cholesterol uptake from the liver and other tissues by the overexpression of LDL receptors [16, 31, 34]. This evidence concerns the gene LDLR and rheumatoid arthritis.